Personally I think our biggest risk is another capital raise which obviously will dilute our holdings. Burning cash with more staff, expanded phase 3, chasing other drugs to repurpose. Lets hope the final uptick in share price is enough to compensate us.
- Forums
- ASX - By Stock
- PAR
- Blind spots
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
5.63%
!
42.3¢

Blind spots, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
42.3¢ |
Change
0.023(5.63%) |
Mkt cap ! $165.9M |
Open | High | Low | Value | Volume |
40.0¢ | 42.3¢ | 39.5¢ | $125.4K | 307.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 12540 | 42.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.5¢ | 14683 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 12540 | 0.420 |
9 | 29446 | 0.415 |
10 | 85988 | 0.410 |
6 | 55792 | 0.405 |
7 | 80033 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.425 | 14683 | 4 |
0.430 | 9309 | 4 |
0.435 | 1540 | 1 |
0.440 | 57622 | 6 |
0.445 | 5800 | 3 |
Last trade - 12.09pm 22/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |